
In the near term, ARC plans to grow into the Netherlands and the UK, while scaling its team from eight to around 25 employees over the next year.

Since the first close in October 2025, Expeditions has nearly doubled the fund's size, exceeding its original fundraising target.

The fresh capital will finance HEALANT's commercial launch, scale up its manufacturing process, and expand its go-to-market and partnership operations.